Comparison of natural histories of human papillomavirus detected by clinician-and self-sampling

International Journal of Cancer

Volumn 127, Issue 8, 2010, Pages 1882-1892

  Moscicki, Anna Barbara ^a   Widdice, Lea ^b   Ma, Yifei ^a   Farhat, Sepideh ^a   Miller Benningfield, Susanna ^a   Jonte, Janet ^a   Jay, Julie ^a   Godwin De Medina, Cheryl ^a   Hanson, Evelyn ^a   Clayton, Lisa ^a   Shiboski, Stephen ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

clinician sampling; HPV natural history; self sampling

Indexed keywords

ADULT; ARTICLE; CANCER SCREENING; CLINICIAN COLLECTED LAVAGE; COMPARATIVE STUDY; DNA VIRUS; FEMALE; HIGH RISK PATIENT; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 11; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; HUMAN PAPILLOMAVIRUS TYPE 26; HUMAN PAPILLOMAVIRUS TYPE 31; HUMAN PAPILLOMAVIRUS TYPE 33; HUMAN PAPILLOMAVIRUS TYPE 35; HUMAN PAPILLOMAVIRUS TYPE 39; HUMAN PAPILLOMAVIRUS TYPE 40; HUMAN PAPILLOMAVIRUS TYPE 42; HUMAN PAPILLOMAVIRUS TYPE 45; HUMAN PAPILLOMAVIRUS TYPE 51; HUMAN PAPILLOMAVIRUS TYPE 52; HUMAN PAPILLOMAVIRUS TYPE 53; HUMAN PAPILLOMAVIRUS TYPE 54; HUMAN PAPILLOMAVIRUS TYPE 55; HUMAN PAPILLOMAVIRUS TYPE 56; HUMAN PAPILLOMAVIRUS TYPE 58; HUMAN PAPILLOMAVIRUS TYPE 59; HUMAN PAPILLOMAVIRUS TYPE 6; HUMAN PAPILLOMAVIRUS TYPE 61; HUMAN PAPILLOMAVIRUS TYPE 62; HUMAN PAPILLOMAVIRUS TYPE 64; HUMAN PAPILLOMAVIRUS TYPE 66; HUMAN PAPILLOMAVIRUS TYPE 67; HUMAN PAPILLOMAVIRUS TYPE 68; HUMAN PAPILLOMAVIRUS TYPE 69; HUMAN PAPILLOMAVIRUS TYPE 70; HUMAN PAPILLOMAVIRUS TYPE 71; HUMAN PAPILLOMAVIRUS TYPE 72; HUMAN PAPILLOMAVIRUS TYPE 73; HUMAN PAPILLOMAVIRUS TYPE 81; HUMAN PAPILLOMAVIRUS TYPE 82; HUMAN PAPILLOMAVIRUS TYPE 83; HUMAN PAPILLOMAVIRUS TYPE 84; HUMAN PAPILLOMAVIRUS TYPE 89; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RANK SUM TEST; SELF COLLECTED SAMPLING; UTERINE CERVIX CANCER; VAGINAL LAVAGE; VIRUS DETECTION; WART VIRUS; ADOLESCENT; CHILD; ISOLATION AND PURIFICATION; METHODOLOGY; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; POLYMERASE CHAIN REACTION; SELF CARE; UTERINE CERVIX TUMOR; VAGINA SMEAR; VIROLOGY;

VIRUS DNA;

ADOLESCENT; ADULT; CHILD; DNA, VIRAL; FEMALE; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; SELF CARE; UTERINE CERVICAL NEOPLASMS; VAGINAL DOUCHING; VAGINAL SMEARS; YOUNG ADULT;

EID: 77956988269     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.25199     Document Type: Article

References (31)

1. Moscicki AB, Shiboski S, Broering J, Powell K, Clayton L, Jay N, Darragh TM, Brescia R, Kanowitz S, Miller SB, Stone J, Hanson E, et al. The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr 1998; 132: 277-84.
2. Moscicki AB, Hills N, Shiboski S, Powell K, Jay N, Hanson E, Miller S, Clayton L, Farhat S, Broering J, Darragh T, Palefsky J,. Risks for incident human papillomavirus infection and low-grade squamous intraepithelial lesion development in young females. JAMA 2001; 285: 2995-3002.
3. Winer RL, Kiviat NB, Hughes JP, Adam DE, Lee SK, Kuypers JM, Koutsky LA,. Development and duration of human papillomavirus lesions, after initial infection. J Infect Dis 2005; 191: 731-8.
4. Wright TC, Jr., Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D,. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol 2007; 197: 346-55.
5. Agorastos T, Dinas K, Lloveras B, Font R, Kornegay JR, Bontis J, de Sanjose S,. Self-sampling versus physician-sampling for human papillomavirus testing. Int J STD AIDS 2005; 16: 727-9.
6. Holanda F, Jr., Castelo A, Veras TM, de Almeida FM, Lins MZ, Dores GB,. Primary screening for cervical cancer through self sampling. Int J Gynaecol Obstet 2006; 95: 179-84.
7. Longatto-Filho A, Roteli-Martins C, Hammes L, Etlinger D, Pereira SM, Erzen M, Branca M, Naud P, Derchain SF, Sarian LO, Matos J, Gontijo R, et al. Self-sampling for human papillomavirus (HPV) testing as cervical cancer screening option. Experience from the LAMS study. Eur J Gynaecol Oncol 2008; 29: 327-32.
8. Nobbenhuis MA, Helmerhorst TJ, van den Brule AJ, Rozendaal L, Jaspars LH, Voorhorst FJ, Verheijen RH, Meijer CJ,. Primary screening for high risk HPV by home obtained cervicovaginal lavage is an alternative screening tool for unscreened women. J Clin Pathol 2002; 55: 435-9.
9. Sellors JW, Lorincz AT, Mahony JB, Mielzynska I, Lytwyn A, Roth P, Howard M, Chong S, Daya D, Chapman W, Chernesky M,. Comparison of self-collected vaginal, vulvar and urine samples with physician-collected cervical samples for human papillomavirus testing to detect high-grade squamous intraepithelial lesions. CMAJ 2000; 163: 513-18.
10. Stenvall H, Wikstrom I, Wilander E,. High prevalence of oncogenic human papilloma virus in women not attending organized cytological screening. Acta Derm Venereol 2007; 87: 243-5.
11. Szarewski A, Cadman L, Mallett S, Austin J, Londesborough P, Waller J, Wardle J, Altman DG, Cuzick J,. Human papillomavirus testing by self-sampling: assessment of accuracy in an unsupervised clinical setting. J Med Screen 2007; 14: 34-42.
12. Baay M, Verhoeven V, Wouters K, Lardon F, Van Damme P, Avonts D, Van Marck E, Van Royen P, Vermorken JB,. The prevalence of the human papillomavirus in cervix and vagina in low-risk and high-risk populations. Scand J Infect Dis 2004; 36: 456-9.
13. Karwalajtys T, Howard M, Sellors JW, Kaczorowski J,. Vaginal self sampling versus physician cervical sampling for HPV among younger and older women. Sex Transm Infect 2006; 82: 337-9.
14. Palmisano ME, Gaffga AM, Daigle J, Brinkman J, Mire K, Lenczyk K, Martin DH, Hagensee ME,. Detection of human papillomavirus DNA in self-administered vaginal swabs as compared to cervical swabs. Int J STD AIDS 2003; 14: 560-7.
15. Petignat P, Faltin DL, Bruchim I, Tramer MR, Franco EL, Coutlee F,. Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing?. A systematic review and meta-analysis. Gynecol Oncol 2007; 105: 530-5.
16. Seo SS, Song YS, Kim JW, Park NH, Kang SB, Lee HP,. Good correlation of HPV DNA test between self-collected vaginal and clinician-collected cervical samples by the oligonucleotide microarray. Gynecol Oncol 2006; 102: 67-73.
17. Stewart DE, Gagliardi A, Johnston M, Howlett R, Barata P, Lewis N, Oliver T, Mai V,. Self-collected samples for testing of oncogenic human papillomavirus: a systematic review. J Obstet Gynaecol Can 2007; 29: 817-28.
18. Baldwin S, Santos C, Mendez Brown E, Nuno T, Giuliano A, Davis J, Garcia F,. Comparison of type-specific human papillomavirus data from self and clinician directed sampling. Gynecol Oncol 2005; 97: 612-17.
19. Scott ME, Ma Y, Farhat S, Shiboski S, Moscicki AB,. Covariates of cervical cytokine mRNA expression by real-time PCR in adolescents and young women: effects of Chlamydia trachomatis infection, hormonal contraception, and smoking. J Clin Immunol 2006; 26: 222-32.
20. Moscicki AB, Shiboski S, Hills NK, Powell KJ, Jay N, Hanson EN, Miller S, Canjura-Clayton L, Farhat S, Broering JM, Darragh TM,. Regression of low-grade squamous intra-epithelial lesions in young women. Lancet 2004; 364: 1678-83.
21. Lin DY, Wei LJ,. The robust inference for the proportional hazards model. J Am Stat Assoc 1989; 84: 1074-78.
22. Munoz N, Castellsague X, de Gonzalez AB, Gissman L,. Chapter 1: HPV in the etiology of human cancer. Vaccine 2006; 24: S31-S311.
23. Muñoz N, Bosch FX, De Sanjose S, Herrero R, Castellsague X, Shah KV, Snijders PJ, Meijer CJ,. Epidemiological classification of human papillomavirus types associated with cervical cancer. New Engl J Med 2003; 348: 518-27.
24. Daling JR, Madeleine MM, Schwartz SM, Shera KA, Carter JJ, McKnight B, Porter PL, Galloway DA, McDougall JK, Tamimi H,. A population-based study of squamous cell vaginal cancer: HPV and cofactors. Gynecol Oncol 2002; 84: 263-70.
25. Richardson H, Kelsall G, Tellier P, Voyer H, Abrahamowicz M, Ferenczy A, Coutlee F, Franco EL,. The natural history of type-specific human papillomavirus infections in female university students. Cancer Epidemiol Biomarkers Prev 2003; 12: 485-90.
26. Munoz N, Mendez F, Posso H, Molano M, van den Brule AJ, Ronderos M, Meijer C, Munoz A,. Incidence, duration, and determinants of cervical human papillomavirus infection in a cohort of Colombian women with normal cytological results. J Infect Dis 2004; 190: 2077-87.
27. Goodman MT, Shvetsov YB, McDuffie K, Wilkens LR, Zhu X, Thompson PJ, Ning L, Killeen J, Kamemoto L, Hernandez BY,. Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study. Cancer Res 2008; 68: 8813-24.
28. Trottier H, Mahmud S, Prado JC, Sobrinho JS, Costa MC, Rohan TE, Villa LL, Franco EL,. Type-specific duration of human papillomavirus infection: implications for human papillomavirus screening and vaccination. J Infect Dis 2008; 197: 1436-47.
29. Insinga RP, Dasbach EJ, Elbasha EH, Liaw KL, Barr E,. Progression and regression of incident cervical HPV 6, 11, 16 and 18 infections in young women. Infect Agent Cancer 2007; 2: 15.
30. Castle PE, Rodriguez AC, Porras C, Herrero R, Schiffman M, Gonzalez P, Hildesheim A, Burk RD,. A comparison of cervical and vaginal human papillomavirus. Sex. Transm. Dis. 2007; 34: 849-55.
31. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD,. Natural History of cervicovaginal papillomavirus infection in young women. New Engl J Med 1998; 338: 423-8.